Clinical Trial Update: Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ibrutinib as early therapy for chronic lymphocytic leukemia and small lymphocytic leukemia; the trial is completed and results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Leukemia

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-09-02